Dual Tyrosine Kinase Inhibitor for Focal Adhesion Kinase and Insulin-like Growth Factor-I Receptor Exhibits Anticancer Effect in Esophageal Adenocarcinoma <i>In vitro</i> and <i>In vivo</i>

Nobuyuki Watanabe, Yoshio Naomoto|Clinical Cancer Research|2008

Cited by 52